[HLA antigens in patients with laryngeal cancer].
The HLA-ABC- and -DR-antigens of patients with carcinoma of the larynx were determined. The frequencies were compared with those of a normal population. No significant deviations in the antigen frequencies were observed in the distribution of HLA antigens. Therefore, participation of HLA-ABC and -DR gene products in pathogenesis of carcinoma of the larynx as an expression of a genetical component cannot be postulated till now.
Beleites
B
B
Klinik für HNO-Krankheiten des Bereiches Medizin, Wilhelm-Pieck-Universität Rostock.
Wegener
S
S
Nowak
R
R
Wilden
G
G
D005260:Female; D005787:Gene Frequency; D006680:HLA Antigens / Q000235:genetics*; D015234:HLA-A Antigens / Q000235:genetics; D015235:HLA-B Antigens / Q000235:genetics; D015236:HLA-C Antigens / Q000235:genetics; D006684:HLA-DR Antigens / Q000235:genetics; D006801:Humans; D007822:Laryngeal Neoplasms / Q000235:genetics*; D008297:Male
D006680:HLA Antigens; D015234:HLA-A Antigens; D015235:HLA-B Antigens; D015236:HLA-C Antigens; D006684:HLA-DR Antigens
HLA-Antigene bei Patienten mit Larynxkarzinom.